Pulmonx Corporation (LUNG) Tops Q2 EPS by 1c, beats revenue

Pulmonx Corporation (NASDAQ: LUNG) reported Q2 EPS of ($0.43), $0.01 better than the analyst estimate of ($0.44). Revenue for the quarter came in at $17.2 million versus the consensus estimate of $15.86 million.

For earnings history and earnings-related data on Pulmonx Corporation (LUNG) click here.

You May Also Be Interested In

• Mizuho says ignore Apple noise, flags key catalyst for Micron and memory in H2
• Jefferies Assumes Allied Blenders (ABDL:IN) at Buy
• Doximity downgraded by BofA on AI investment concerns, margin pressure